Xeris Biopharma Inc. (XERS)
NASDAQ: XERS
· Real-Time Price · USD
8.13
0.28 (3.57%)
At close: Sep 26, 2025, 1:13 PM
Xeris Biopharma Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for XERS stock have an median target of 8.5, with a low estimate of 4 and a high estimate of 11. The median target predicts an increase of 4.55% from the current stock price of 8.13.
| Target | Low | Average | Median | High |
|---|---|---|---|---|
| Price | 4 | 8 | 8.5 | 11 |
| Change | -50.80% | -1.60% | 4.55% | 35.30% |
Latest Analyst Insight Report
Oppenheimer maintains an Outperform rating on Xeri... Unlock content with Pro Subscription
Updated May 09, 2025
| Rating | Nov 24 | Jan 25 | Mar 25 | May 25 | Jun 25 | Aug 25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 2 | 0 | 0 | 1 |
| Buy | 0 | 0 | 1 | 1 | 1 | 3 |
| Hold | 1 | 0 | 1 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 1 | 4 | 1 | 1 | 4 |
Financial Forecast this Year
Revenue This Year
286.47M
from 203.07M
Increased by 41.1%
Revenue Next Year
348.68M
from 286.47M
Increased by 21.7%
EPS This Year
-0.02
from -0.37
Increased by 94.6%
EPS Next Year
0.25
from -0.02
Increased by -1.15K%